1. Home
  2. WASH vs ENGN Comparison

WASH vs ENGN Comparison

Compare WASH & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Washington Trust Bancorp Inc.

WASH

Washington Trust Bancorp Inc.

HOLD

Current Price

$29.59

Market Cap

585.9M

Sector

Finance

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.93

Market Cap

605.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WASH
ENGN
Founded
1800
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
585.9M
605.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WASH
ENGN
Price
$29.59
$8.93
Analyst Decision
Hold
Buy
Analyst Count
4
7
Target Price
$30.25
$22.71
AVG Volume (30 Days)
115.1K
248.6K
Earning Date
01-28-2026
12-22-2025
Dividend Yield
7.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$117,341,000.00
N/A
Revenue This Year
$57.78
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.95
$2.65
52 Week High
$34.13
$11.14

Technical Indicators

Market Signals
Indicator
WASH
ENGN
Relative Strength Index (RSI) 48.68 56.96
Support Level $30.04 $7.57
Resistance Level $30.40 $9.81
Average True Range (ATR) 0.51 0.72
MACD -0.20 0.03
Stochastic Oscillator 11.50 55.73

Price Performance

Historical Comparison
WASH
ENGN

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: